Boston Scientific to acquire Baylis Medical for $1.75bn
The acquisition will add Baylis Medical’s cardiology products to Boston Scientific’s electrophysiology and structural heart pipelines
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Oct 21
The acquisition will add Baylis Medical’s cardiology products to Boston Scientific’s electrophysiology and structural heart pipelines
06 Oct 21
The investment will enhance production capabilities in Alajuela, Costa Rica and Turku, Finland, to meet global demand for…
30 Sep 21
Clean labels and simple ingredients are becoming priorities for health-conscious consumers. What role do they play in our…
24 Sep 21
The acquisition will help GE Healthcare to expand its $3bn ultrasound business from diagnostics into the surgical space
09 Sep 21
The acquisition will add Rezurock, an FDA-approved treatment for chronic graft-versus-host disease (cGVHD), to Sanofi’s transplant portfolio
07 Sep 21
Adjusting treatments according to individual patients can be a painstaking process, but gathering biomarkers can make that tailoring…
02 Sep 21
Thermo Fisher said that NGS-based CDx are widely used to match patients with new treatments for cancer and…
31 Aug 21
The new C.1.2 variant has now spread to various provinces in South Africa, and seven other countries in…
30 Aug 21
Vivistim System is a drug-free rehabilitation system that leverages vagus nerve stimulation (VNS) and can be used in…
23 Aug 21
The antibody cocktail comprises casirivimab and imdevimab and leverages Regeneron's VelocImmune and VelociSuite technologies